NALOXONE REVERSAL OF CHOLEDOCHODUODENAL SPHINCTER SPASM ASSOCIATED WITH NARCOTIC ADMINISTRATION

被引:38
|
作者
MCCAMMON, RL
VIEGAS, OJ
STOELTING, RK
DRYDEN, GE
机构
关键词
D O I
10.1097/00000542-197806000-00011
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:437 / 437
页数:1
相关论文
共 50 条
  • [2] NARCOTIC-INDUCED CHOLEDOCHODUODENAL SPHINCTER SPASM REVERSED BY GLUCAGON
    JONES, RM
    FIDDIANGREEN, R
    KNIGHT, PR
    ANESTHESIA AND ANALGESIA, 1980, 59 (12): : 946 - 947
  • [3] REVERSAL OF NARCOTIC DEPRESSION IN NEONATE BY NALOXONE
    EVANS, JM
    HOGG, MIJ
    ROSEN, M
    BRITISH MEDICAL JOURNAL, 1976, 2 (6044): : 1098 - 1100
  • [4] INCIDENCE OF CHOLEDOCHODUODENAL SPHINCTER SPASM DURING FENTANYL-SUPPLEMENTED ANESTHESIA
    JONES, RM
    DETMER, M
    HILL, AB
    BJORAKER, DG
    PANDIT, U
    ANESTHESIA AND ANALGESIA, 1981, 60 (09): : 638 - 640
  • [5] NALOXONE REVERSAL OF NYSTAGMUS ASSOCIATED WITH INTRATHECAL MORPHINE ADMINISTRATION
    UEYAMA, H
    NISHIMURA, M
    TASHIRO, C
    ANESTHESIOLOGY, 1992, 76 (01) : 153 - 153
  • [6] REVERSAL OF FENTANYL INDUCED SPASM OF THE SPHINCTER OF ODDI
    MCCAMMON, RL
    STOELTING, R
    MADURA, JA
    SURGERY GYNECOLOGY & OBSTETRICS, 1983, 156 (03): : 329 - 334
  • [7] NARCOTIC REVERSAL IN HYPERCAPNIC DOGS - COMPARISON OF NALOXONE AND NALBUPHINE
    MILLS, CA
    FLACKE, JW
    FLACKE, WE
    BLOOR, BC
    LIU, MD
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1990, 37 (02): : 238 - 244
  • [8] CHOLANGIOGRAPHIC DEMONSTRATION OF RELIEF OF NARCOTIC-INDUCED SPASM OF THE SPHINCTER OF ODDI
    MCLEAN, ER
    WIDMANN, WD
    SMALL, HS
    AMERICAN SURGEON, 1982, 48 (03) : 134 - 136
  • [9] NALOXONE REVERSAL OF KETOBEMIDONE INDUCED RESPIRATORY, CIRCULATORY AND NARCOTIC EFFECTS IN DOGS
    AASEN, AO
    HOLSTLARSEN, H
    ORMSTAD, K
    RUGSTAD, HE
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1977, 41 : 118 - 128
  • [10] AGONISTIC PROPERTIES OF NARCOTIC ANALGESICS AND ANTAGONISTS ON ELECTROENCEPHALOGRAM AND BEHAVIOR IN RAT AND THEIR REVERSAL BY NALOXONE
    COLASANTI, B
    KHAZAN, N
    NEUROPHARMACOLOGY, 1973, 12 (07) : 619 - 627